http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2081121-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B60C27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B60C27-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D503-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D503-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D503-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D503-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D503-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B63-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
filingDate 1993-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f57ed7cfd3c06be635a678822800280
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda2c41fbc7ff8e301e4782eec19c637
publicationDate 1997-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2081121-C1
titleOfInvention Method of synthesis of clavulanic acid or its pharmaceutically acceptable salts and ethers, clavulanic acid salt with amine
abstract FIELD: chemical technology. SUBSTANCE: invention proposes method of synthesis and/or purification of clavulanic acid or its pharmaceutically acceptable salts or ethers. Method involves contact of crude clavulanic acid or its labile derivative in organic solvent with amine of the formula (II): where: R I - group of the formula ; R 2 , R 3 , R 4 , R 5 - hydrogen or C 1 -C 6 -alkyl; m = 0-5. Invention relates to also isolation of clavulanic salt formed with amine, conversion of salt to clavulanic acid or its pharmaceutically acceptable salt or ether. Invention proposes also clavulanic acid salt and amine of the formula (II) . EFFECT: improved method of synthesis. 40 cl
priorityDate 1992-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538481
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3424274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452696754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23669619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53628223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453520888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411746874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104770
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451859813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411832430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415763164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454670996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283

Total number of triples: 90.